Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Sydney 2010, Australia.
Trends Endocrinol Metab. 2012 Mar;23(3):116-24. doi: 10.1016/j.tem.2011.12.005. Epub 2012 Jan 26.
In most humans, obesity and insulin resistance coexist. However, a unique group of obese individuals, who exhibit better insulin sensitivity than expected for their adiposity, has been the focus of recent research interest. We critically examine cross-sectional and lifestyle intervention studies in obese humans classified as 'insulin-sensitive' versus 'insulin-resistant' and review the few longitudinal studies comparing rates of cardiovascular disease, type 2 diabetes and all-cause mortality in these groups of individuals. We suggest that reduced deposition of fat, particularly of bioactive lipid intermediates, in muscle and liver is potentially protective. We propose that dynamic interventional studies in insulin-sensitive obese humans may increase understanding of the metabolic factors that play a role in obesity-associated insulin resistance in humans.
在大多数人中,肥胖症和胰岛素抵抗并存。然而,最近的研究兴趣集中在一类独特的肥胖人群上,他们的胰岛素敏感性优于预期的体脂含量。我们批判性地审查了肥胖人群中分类为“胰岛素敏感”和“胰岛素抵抗”的横断面和生活方式干预研究,并回顾了少数比较这些人群心血管疾病、2 型糖尿病和全因死亡率的纵向研究。我们认为,肌肉和肝脏中脂肪,特别是生物活性脂质中间产物的沉积减少可能具有保护作用。我们建议,对胰岛素敏感的肥胖人群进行动态干预研究,可能会增加对人类肥胖相关胰岛素抵抗中起作用的代谢因素的理解。